6.
Cisneros I, Ghorpade A
. Methamphetamine and HIV-1-induced neurotoxicity: role of trace amine associated receptor 1 cAMP signaling in astrocytes. Neuropharmacology. 2014; 85:499-507.
PMC: 4315503.
DOI: 10.1016/j.neuropharm.2014.06.011.
View
7.
Shemiakova T, Efimova E, Gainetdinov R
. TAARs as Novel Therapeutic Targets for the Treatment of Depression: A Narrative Review of the Interconnection with Monoamines and Adult Neurogenesis. Biomedicines. 2024; 12(6).
PMC: 11200894.
DOI: 10.3390/biomedicines12061263.
View
8.
Lagerberg T, Fazel S, Sjolander A, Hellner C, Lichtenstein P, Chang Z
. Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study. Neuropsychopharmacology. 2021; 47(4):817-823.
PMC: 8882171.
DOI: 10.1038/s41386-021-01179-z.
View
9.
Angoa-Perez M, Kane M, Briggs D, Francescutti D, Kuhn D
. Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J Vis Exp. 2014; (82):50978.
PMC: 4108161.
DOI: 10.3791/50978.
View
10.
Welch J, Lu J, Rodriguiz R, Trotta N, Peca J, Ding J
. Cortico-striatal synaptic defects and OCD-like behaviours in Sapap3-mutant mice. Nature. 2007; 448(7156):894-900.
PMC: 2442572.
DOI: 10.1038/nature06104.
View
11.
Newman-Tancredi A, Conte C, Chaput C, Spedding M, Millan M
. Inhibition of the constitutive activity of human 5-HT1A receptors by the inverse agonist, spiperone but not the neutral antagonist, WAY 100,635. Br J Pharmacol. 1997; 120(5):737-9.
PMC: 1564555.
DOI: 10.1038/sj.bjp.0701025.
View
12.
Shmelkov S, Hormigo A, Jing D, Proenca C, Bath K, Milde T
. Slitrk5 deficiency impairs corticostriatal circuitry and leads to obsessive-compulsive-like behaviors in mice. Nat Med. 2010; 16(5):598-602, 1p following 602.
PMC: 2907076.
DOI: 10.1038/nm.2125.
View
13.
Black S, Schwartz M, Chen T, Hoener M, Kilduff T
. Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics. Biol Psychiatry. 2016; 82(9):623-633.
PMC: 5395352.
DOI: 10.1016/j.biopsych.2016.10.012.
View
14.
Leo D, Targa G, Espinoza S, Villers A, Gainetdinov R, Ris L
. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease. Int J Mol Sci. 2022; 23(14).
PMC: 9318502.
DOI: 10.3390/ijms23147811.
View
15.
Jannini T, Lorenzo G, Bianciardi E, Niolu C, Toscano M, Ciocca G
. Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs). Curr Neuropharmacol. 2021; 20(4):693-712.
PMC: 9878961.
DOI: 10.2174/1570159X19666210517150418.
View
16.
Mahadevia D, Saha R, Manganaro A, Chuhma N, Ziolkowski-Blake A, Morgan A
. Dopamine promotes aggression in mice via ventral tegmental area to lateral septum projections. Nat Commun. 2021; 12(1):6796.
PMC: 8610979.
DOI: 10.1038/s41467-021-27092-z.
View
17.
Gilbert P, McEwan K, Irons C, Bhundia R, Christie R, Broomhead C
. Self-harm in a mixed clinical population: the roles of self-criticism, shame, and social rank. Br J Clin Psychol. 2010; 49(Pt 4):563-76.
DOI: 10.1348/014466509X479771.
View
18.
Alnefeesi Y, Sukhanov I, Gainetdinov R
. Ligands of the trace amine-associated receptors (TAARs): A new class of anxiolytics. Pharmacol Biochem Behav. 2024; 242():173817.
DOI: 10.1016/j.pbb.2024.173817.
View
19.
Brummelte S, Mc Glanaghy E, Bonnin A, Oberlander T
. Developmental changes in serotonin signaling: Implications for early brain function, behavior and adaptation. Neuroscience. 2016; 342:212-231.
PMC: 5310545.
DOI: 10.1016/j.neuroscience.2016.02.037.
View
20.
Euston D, Gruber A, McNaughton B
. The role of medial prefrontal cortex in memory and decision making. Neuron. 2012; 76(6):1057-70.
PMC: 3562704.
DOI: 10.1016/j.neuron.2012.12.002.
View